Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.83 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.83 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.83 |
| ▸ | MEN1 | O00255 | 1/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.83 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | ENPP2 | Q13822 | 6/20 | 0.76 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.76 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.76 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.76 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.76 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.76 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.76 |
| ▸ | DGKA | P23743 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.65 |
| ▸ | CES2 | O00748 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11787098 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL7576639 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL9463709 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL3109961 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL21660226 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL3941258 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL2734722 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL17129723 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL2183839 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL19944297 | 1.00 | LMNA (0.83) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034089-A1 | APPLICATION OF MEDIUM-CHAIN FATTY ACID MIXED STRUCTURAL LIPID IN IMPROVING DIET-INDUCED DISORDERS OF GLUCOSE AND LIPID METABOLISM | HANGZHOU KANGYUAN FOOD TECH CO LTD (CN) | 2026-02-05 | — | — | US | disclosed |
| CN-118592613-B | Use of medium chain fatty acid mixed structured lipid for improving diet induced glycolipid metabolic disorder | 杭州康源食品科技有限公司 | 2025-01-07 | — | — | CN | disclosed |
| US-11975073-B2 | Lipid prodrugs of neurosteroids | PURETECH LYT, INC. (US) | 2024-05-07 | — | — | US | disclosed |
| US-11938137-B2 | Lipid prodrugs of mycophenolic acid and uses thereof | PURETECH LYT, INC. (US) | 2024-03-26 | — | — | US | disclosed |
| US-11883497-B2 | Lymphatic system-directing lipid prodrugs | PURETECH LYT, INC. (US) | 2024-01-30 | — | — | US | disclosed |
| EP-4306524-A2 | LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS | PureTech LYT, Inc. (US) | 2024-01-17 | — | — | EP | disclosed |
| US-20230338552-A1 | LIPID PRODRUGS OF NEUROSTEROIDS | PURETECH LYT, INC. (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230338552-A1 | LIPID PRODRUGS OF NEUROSTEROIDS | PURETECH LYT, INC. (US) | 2023-10-26 | — | — | US | disclosed |
| US-20220395513-A1 | LIPID PRODRUGS OF NEUROSTEROIDS | PURETECH LYT, INC. (US) | 2022-12-15 | — | — | US | disclosed |
| US-20220143038-A1 | LIPID PRODRUGS OF MYCOPHENOLIC ACID AND USES THEREOF | PURETECH LYT, INC. (US) | 2022-05-12 | — | — | US | disclosed |
| US-5137660-A | Regioselective synthesis of 1,3-disubstituted glycerides | THE PROCTER & GAMBLE COMPANY (US) | 1992-08-11 | — | — | US | disclosed |
| EP-0187297-B1 | ALKOXY METHYL ETHER AND ALKOXY METHYL ESTER DERIVATIVES | SYNTEX (U.S.A.) INC. (US) | 1991-08-21 | — | — | EP | disclosed |
| WO-1991007168-A1 | RIBOFLAVIN AS A TANNING ENHANCER | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1991-05-30 | — | — | WO | disclosed |
| WO-1991007167-A1 | PROTEIN KINASE ACTIVATORS AS ENHANCERS OF MELANIN PRODUCTION | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1991-05-30 | — | — | WO | disclosed |
| US-4855287-A | ANTIBIOTICS | KOWA COMPANY, LTD. (JP) | 1989-08-08 | — | — | US | disclosed |
| US-4654370-A | TREATING EPILEPTIC SEIZURES | ABBOTT LABORATORIES (US) | 1987-03-31 | — | — | US | disclosed |
| EP-0187297-A2 | Alkoxy methyl ether and alkoxy methyl ester derivatives | SYNTEX (U.S.A.) INC. (US) | 1986-07-16 | — | — | EP | disclosed |
| US-4178299-A | Process for preparing 1,3-diacyl glycerols | ABBOTT LABORATORIES (US) | 1979-12-11 | — | — | US | disclosed |
| US-4137317-A | Glycerides with antibacterial properties | ABBOTT LABORATORIES (US) | 1979-01-30 | — | — | US | disclosed |
| US-4046887-A | Glycerides with anti-inflammatory properties | ABBOTT LABORATORIES (US) | 1977-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230338552-A1 | LIPID PRODRUGS OF NEUROSTEROIDS | CYP21A2, CYP46A1, CYP17A1 | LMNA 2962/4885KDM4E 2859/4885DUSP3 956/4885 |
| US-11938137-B2 | Lipid prodrugs of mycophenolic acid and uses thereof | MALT1, CYP2B6, LIPA | LMNA 4002/4885KDM4E 1491/4885DUSP3 24/4885 |
| US-20220395513-A1 | LIPID PRODRUGS OF NEUROSTEROIDS | CYP21A2, CYP46A1, CYP17A1 | LMNA 2962/4885KDM4E 2859/4885DUSP3 956/4885 |
| US-20260034089-A1 | APPLICATION OF MEDIUM-CHAIN FATTY ACID MIXED STRUCTURAL LIPID IN IMPROVING DIET-INDUCED DISORDERS OF GLUCOSE AND LIPID METABOLISM | LIPC, MGLL, LPL | LMNA 771/4885KDM4E 1541/4885DUSP3 2458/4885 |
| US-20220143038-A1 | LIPID PRODRUGS OF MYCOPHENOLIC ACID AND USES THEREOF | MALT1, CYP2B6, LIPA | LMNA 4002/4885KDM4E 1491/4885DUSP3 24/4885 |
| US-11883497-B2 | Lymphatic system-directing lipid prodrugs | LIPA, MALT1, SGMS1 | LMNA 2779/4885KDM4E 2135/4885DUSP3 445/4885 |
| US-11975073-B2 | Lipid prodrugs of neurosteroids | CYP21A2, CYP46A1, CYP17A1 | LMNA 2962/4885KDM4E 2859/4885DUSP3 956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.